Table 3.
Platelet and aggregability data of healthy controls and post-stroke patients grouped on their responder status
| Control group (n = 15) | Responder (n = 34) | Non-responder (n = 12) | p-value | |
| PLT count upper (G/L) | 316 (218–478) | 343 (284–408) | 372 (302–478) | 0.39 |
| PLT count lower (G/L) | 88 (51–124) | 73 (53–86) | 65 (54–90) | 0.95 |
| PAR (%) | 58.5 (45.0–67.5) | 67.1 (57.6–71.0) | 71.8 (62.6–74.3) | 0.16 |
| MPV (fl) upper | 10.7 (10.0–10.8) | 10.05 (9.7–10.8) | 10.32 (10.1–10.8) | 0.83 |
| MPV (fl) lower | 10.0 (9.8–10.6) | 10.45 (9.75–11.22) | 10.40 (9.8–11.1) | 0.95 |
| PLCR upper (%) | 28.9 (24.5–30.6) | 32.65 (25.02–37.92) | 36.95 (27.4–38.9) | 0.37 |
| PLCR lower (%) | 25.5 (22.7–28.7) | 30.2 (23.5–37.7) | 32.25 (26.5–36.8) | 0.51 |
| H-IPF upper (%) | 0.9 (0.8–1.35) | 1.2 (0.8–1.4) | 1.7 (1.15–2.0) | 0.04* |
| H-IPF lower (%) | 0.8 (0.8–1.0) | 0.7 (0.6–1.2) | 0.9 (0.7–1.5) | 0.54 |
| AUC | 73.5 (59.5–78.5) | 36.5 (27.0–42.2) | 66.0 (59–74.5) | <0.001 |
| AUC upper | 112.5 (73.0–137) | 49 (23.0–63.0) | 93 (65.5–107.5) | <0.001 |
| AUC lower | 23.0 (16.0–35.0) | 17 (13.0–21.0) | 21.5 (17.0–30.5) | 0.03 |